Dechra Pharmaceuticals Plc Stock Z Score
DPHAYDelisted Stock | USD 93.78 0.00 0.00% |
Dechra |
Dechra Pharmaceuticals PLC Company Z Score Analysis
Dechra Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Dechra Pharmaceuticals Z Score | 7.8 |
Most of Dechra Pharmaceuticals' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dechra Pharmaceuticals PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Dechra Pharmaceuticals PLC has a Z Score of 7.8. This is 15.56% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The z score for all United States stocks is 10.55% higher than that of the company.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
Dechra Fundamentals
Return On Equity | 0.0896 | |||
Return On Asset | 0.0478 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.14 % | |||
Current Valuation | 4.04 B | |||
Shares Outstanding | 56.92 M | |||
Shares Owned By Institutions | 0.09 % | |||
Price To Book | 4.99 X | |||
Price To Sales | 5.65 X | |||
Revenue | 681.8 M | |||
Gross Profit | 384.8 M | |||
EBITDA | 178.9 M | |||
Net Income | 58.2 M | |||
Cash And Equivalents | 123.7 M | |||
Cash Per Share | 2.29 X | |||
Total Debt | 313.7 M | |||
Debt To Equity | 0.49 % | |||
Current Ratio | 2.91 X | |||
Book Value Per Share | 12.30 X | |||
Cash Flow From Operations | 122.9 M | |||
Earnings Per Share | 1.29 X | |||
Number Of Employees | 2 K | |||
Beta | 0.68 | |||
Market Capitalization | 4.3 B | |||
Total Asset | 1.29 B | |||
Z Score | 7.8 | |||
Annual Yield | 0.01 % | |||
Net Asset | 1.29 B | |||
Last Dividend Paid | 0.45 |
About Dechra Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dechra Pharmaceuticals PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dechra Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dechra Pharmaceuticals PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Dechra Pink Sheet
If you are still planning to invest in Dechra Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dechra Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |